Review Articles

The Evolution of Risk Assessment in Pulmonary Arterial Hypertension

Authors:

Abstract

Pulmonary arterial hypertension (PAH) is a chronic debilitating disease that carries an unacceptably high morbidity and mortality rate despite improved survival with modern therapies. The combination of several modifiable and nonmodifiable variables yields a robust risk assessment across various available clinical calculators. The role of risk calculation is integral to managing PAH and aids in the timely referral to expert centers and potentially lung transplantation. Studies are ongoing to determine the role of risk calculators in the framework of clinical trials and to elucidate novel markers of high risk in PAH.

Keywords:

riskpulmonary arterial hypertensionsurvivalprognosis
  • Year: 2021
  • Volume: 17 Issue: 2
  • Page/Article: 134-144
  • DOI: 10.14797/LRPR7655
  • Accepted on 18 Nov 2020
  • Published on 1 Jul 2021
  • Peer Reviewed